Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alexander Vlaar and Matthijs Brouwer.
Alexander Vlaar
Connection Strength
0.634
Matthijs Brouwer
  1. Efficacy matters: broadening complement inhibition in COVID-19 - Authors' reply. Lancet Rheumatol. 2021 Feb; 3(2):e95-e96.
    View in: PubMed
    Score: 0.230
  2. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
    View in: PubMed
    Score: 0.226
  3. Sex steroid hormones are associated with mortality in COVID-19 patients: Level of sex hormones in severe COVID-19. Medicine (Baltimore). 2021 Aug 27; 100(34):e27072.
    View in: PubMed
    Score: 0.060
  4. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021 May; 67:103378.
    View in: PubMed
    Score: 0.059
  5. Complement inhibition in severe COVID-19 - Blocking C5a seems to be key. EClinicalMedicine. 2021 May; 35:100722.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.